A new editorial was recently published in Oncotarget's Volume 15, on July 10, 2024, entitled, "The advances in targeting CD47/SIRPα "do not eat me"...

A new editorial was recently published in Oncotarget's Volume 15, on July 10, 2024, entitled, "The advances in targeting CD47/SIRPα "do not eat me"...

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder.

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder.

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a...

Oncolytics Biotech (TSX:ONC) revealed results from its Phase 2 study in patients with advanced or metastatic breast cancer.

New research shows that breast cancer screening with digital breast tomosynthesis significantly raises detection rates and lowers advanced cancer...

MONDAY, Sept. 16, 2024 -- For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of...

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and...